Jamieson Wellness Inc. (OTCMKTS:JWLLF) Short Interest Up 419.6% in July

Jamieson Wellness Inc. (OTCMKTS:JWLLF) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 404,709 shares, an increase of 419.6% from the July 15th total of 77,891 shares. Based on an average trading volume of 12,221 shares, the short-interest ratio is presently 33.1 days.

Jamieson Wellness Stock Performance

OTCMKTS:JWLLF remained flat at $32.77 during trading hours on Friday. 500 shares of the company’s stock were exchanged, compared to its average volume of 3,342. Jamieson Wellness has a 1-year low of $23.88 and a 1-year high of $32.78. The stock has a fifty day moving average price of $28.77 and a 200-day moving average price of $26.61.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Citigroup downgraded Jamieson Wellness to a “hold” rating in a research note on Friday, August 7th. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of Jamieson Wellness in a report on Friday, May 8th. Royal Bank Of Canada lowered Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research note on Monday. Finally, National Bank Financial restated an “outperform” rating on shares of Jamieson Wellness in a report on Friday, June 26th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.

Jamieson Wellness Company Profile

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.